Nova Eye Medical (EYE) Discussion, page-1120

Hope this isn’t too grim for a Sunday afternoon read, but I have been doing some more research on PEB and their reimbursement situation. It was interesting to note that the company in that case also believed the probability of their proposed LCD being implemented was very low, and stated this in an announcement released to the market. Their reasons were similar, citing strong evidence and the importance of their device for patients. So it seems like the outcomes of these proposals are unpredictable, which is definitely a bit concerning. I’ll attach it below:


Not sure what to think about this. I guess this is just one example, and they have been successful in negotiating a stay of the LCD and a new revised LCD (though their share price remains at all time lows). So this could very well be an unusual example. Still, down 70% on the day the LCD was finalised and down a lot more since it was first proposed. Definitely a risk which needs to be accounted for. Hopefully it is covered in depth by the company when they present tomorrow



And let’s hope this isn’t us!!!!! The sooner these guys can make a decision the better, last thing we want is for this to drag on the full year (as it did for PEB) as that definitely won’t help!